Multiplikator Forward P/S: Intelligent Bio Solutions Inc (INBS)
Intelligent Bio Solutions is facing a liquidity shortage and a need for borrowed funds. The projected P/S metric on GURU.Markets reflects expectation dynamics, where the indicator level stands at 1.40. This underscores the value of the company's unique non-invasive sweat tests, although concerns regarding certification rigor and potential lawsuits over diagnostic accuracy act as headwinds.
Ringkesan rincian data analitis ibs.inc (INBS)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Intelligent Bio Solutions|INBS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Intelligent Bio Solutions Inc.|INBS - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku INBS|INBS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Intelligent Bio Solutions|Rasio cepet ibs.inc
- rincian asil keuangan lan kelipatan valuasi:
INBS - Penghasilan resik perusahaan|Bathi sing dikarepake Intelligent Bio Solutions|INBS - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Intelligent Bio Solutions Inc.|INBS - Pangali PEG|Pangali EV/EBITDA INBS|INBS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Intelligent Bio Solutions|INBS - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ibs.inc|INBS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Intelligent Bio Solutions
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:INBS (Intelligent Bio)
Investors are finding it difficult to balance current stock volatility with long-term revenue growth prospects. Analyzing the forward price-to-sales chart allows for the determination of the deviation of market value from expected earnings, which is critical for Intelligent Bio Solutions (INBS), as its capitalization currently depends directly on successful FDA certification to scale rapid testing in the US market.
Karo sapa Intelligent Bio Solutions saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|PFSA - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|Kapitalisasi marang prakiraan pendapatan GCTK (glucotrack.com)|Multiplikator forward rega marang pendapatan NAOV (NanoVibronix)|Rasio rega marang pendapatan sing dikarepake VERO|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|aethlonmedical.com (AEMD) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ASXC - Rasio rega marang prakiraan pendapatan|AVGR: Rasio rega marang prakiraan pendapatan|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|CUTR (Cutera Inc) - Rasio rega marang prakiraan pendapatan|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|inarimedical.com (NARI) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S NVRO|reshapelifesciences.com (RSLS) - Prakiraan rega marang pendapatan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
